OBJECTIVE: To determine whether calcium-permeable channels are targets for the oxidized phospholipids: 1-palmitoyl-2-glutaroyl-phosphatidylcholine (PGPC) and 1-palmitoyl-2-oxovaleroyl-phosphatidylcholine (POVPC). METHODS AND RESULTS: Oxidized phospholipids are key factors in inflammation and associated diseases, including atherosclerosis; however, the initial reception mechanisms for cellular responses to the factors are poorly understood. Low micromolar concentrations of PGPC and POVPC evoked increases in intracellular calcium in human embryonic kidney 293 cells that overexpressed human transient receptor potential canonical 5 (TRPC5) but not human TRP melastatin (TRPM) 2 or 3. The results of electrophysiological experiments confirmed stimulation of TRPC5. To investigate relevance to endogenous channels, we studied proliferating vascular smooth muscle cells from patients undergoing coronary artery bypass surgery. PGPC and POVPC elicited calcium entry that was inhibited by anti-TRPC5 or anti-TRPC1 antibodies or dominant-negative mutant TRPC5. Calcium release did not occur. The effect was functionally relevant because it enhanced cell migration. The actions of PGPC and POVPC depended on G(i/o) proteins but not on previously identified G protein-coupled receptors for oxidized phospholipids. CONCLUSIONS: Stimulation of calcium-permeable TRPC5-containing channels may be an early event in cellular responses to oxidized phospholipids that couples to cell migration and requires an unidentified G protein-coupled receptor.
OBJECTIVE: To determine whether calcium-permeable channels are targets for the oxidized phospholipids: 1-palmitoyl-2-glutaroyl-phosphatidylcholine (PGPC) and 1-palmitoyl-2-oxovaleroyl-phosphatidylcholine (POVPC). METHODS AND RESULTS: Oxidized phospholipids are key factors in inflammation and associated diseases, including atherosclerosis; however, the initial reception mechanisms for cellular responses to the factors are poorly understood. Low micromolar concentrations of PGPC and POVPC evoked increases in intracellular calcium in humanembryonic kidney 293 cells that overexpressed humantransient receptor potential canonical 5 (TRPC5) but not human TRP melastatin (TRPM) 2 or 3. The results of electrophysiological experiments confirmed stimulation of TRPC5. To investigate relevance to endogenous channels, we studied proliferating vascular smooth muscle cells from patients undergoing coronary artery bypass surgery. PGPC and POVPC elicited calcium entry that was inhibited by anti-TRPC5 or anti-TRPC1 antibodies or dominant-negative mutant TRPC5. Calcium release did not occur. The effect was functionally relevant because it enhanced cell migration. The actions of PGPC and POVPC depended on G(i/o) proteins but not on previously identified G protein-coupled receptors for oxidized phospholipids. CONCLUSIONS: Stimulation of calcium-permeable TRPC5-containing channels may be an early event in cellular responses to oxidized phospholipids that couples to cell migration and requires an unidentified G protein-coupled receptor.
Authors: A D Watson; N Leitinger; M Navab; K F Faull; S Hörkkö; J L Witztum; W Palinski; D Schwenke; R G Salomon; W Sha; G Subbanagounder; A M Fogelman; J A Berliner Journal: J Biol Chem Date: 1997-05-23 Impact factor: 5.157
Authors: G Subbanagounder; N Leitinger; D C Schwenke; J W Wong; H Lee; C Rizza; A D Watson; K F Faull; A M Fogelman; J A Berliner Journal: Arterioscler Thromb Vasc Biol Date: 2000-10 Impact factor: 8.311
Authors: Karen E Porter; Jagjeeth Naik; Neil A Turner; Timothy Dickinson; Matthew M Thompson; Nicholas J M London Journal: J Vasc Surg Date: 2002-07 Impact factor: 4.268
Authors: Mohamad Navab; G M Ananthramaiah; Srinivasa T Reddy; Brian J Van Lenten; Benjamin J Ansell; Gregg C Fonarow; Kambiz Vahabzadeh; Susan Hama; Greg Hough; Naeimeh Kamranpour; Judith A Berliner; Aldons J Lusis; Alan M Fogelman Journal: J Lipid Res Date: 2004-04-01 Impact factor: 5.922
Authors: Yasser Majeed; Yahya Bahnasi; Victoria A L Seymour; Lesley A Wilson; Carol J Milligan; Anil K Agarwal; Piruthivi Sukumar; Jacqueline Naylor; David J Beech Journal: Mol Pharmacol Date: 2011-03-15 Impact factor: 4.436
Authors: Jacqueline Naylor; Eman Al-Shawaf; Lynn McKeown; Paul T Manna; Karen E Porter; David O'Regan; Katsuhiko Muraki; David J Beech Journal: J Biol Chem Date: 2010-12-02 Impact factor: 5.157
Authors: Piruthivi Sukumar; Alicia Sedo; Jing Li; Lesley A Wilson; David O'Regan; Jonathan D Lippiat; Karen E Porter; Mark T Kearney; Justin F X Ainscough; David J Beech Journal: Circ Res Date: 2012-06-05 Impact factor: 17.367
Authors: Y Majeed; M S Amer; A K Agarwal; L McKeown; K E Porter; D J O'Regan; J Naylor; C W G Fishwick; K Muraki; D J Beech Journal: Br J Pharmacol Date: 2011-04 Impact factor: 8.739